Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Change in Accured Expenses (2018 - 2026)

Updated

Regenerative Medical Technology's Change in Accured Expenses was $1.75 million in Q2 2026, up 162.8% from $664,997 a year earlier and up 18.6% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Change in Accured Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regenerative Medical Technology's Change in Accured Expenses was $7.79 million through Jun 30, 2026, up 114.6% year-over-year; for FY2025, it came in at $6.15 million, up 49.8% from FY2024.

  • Change in Accured Expenses has now increased for seven consecutive years, with a five-year compound annual growth rate of 41.3% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $4.1 million in FY2024 (+20.3%), $3.41 million in FY2023 (+35.5%), $2.52 million in FY2022 (+92.6%) and $1.31 million in FY2021 (+19.6%).
  • Quarterly Change in Accured Expenses has moved between $413,290 (Q4 2022) and $3.19 million (Q3 2025) over five years.
  • Compared with a year earlier, Change in Accured Expenses has increased for four straight quarters, with growth averaging 57.6% over the last eight quarters.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q1 2022 (growth of 257.9%); the worst was Q4 2021 (a decline of 46.0%).
  • Per Business Quant data, RMTG's Change in Accured Expenses in the three quarters before Q2 2026 was $1.47 million (Q1 2026), $1.39 million (Q4 2025) and $3.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 1.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Mn
Mar 31, 2026 1.47 Mn
Dec 31, 2025 1.39 Mn
Sep 30, 2025 3.19 Mn
Jun 30, 2025 664,997.00
Mar 31, 2025 908,279.00
Dec 31, 2024 1.04 Mn
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.03 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 875,995.00
Sep 30, 2023 873,972.00
Jun 30, 2023 750,000.00
Mar 31, 2023 911,816.00
Dec 31, 2022 413,290.00
Sep 30, 2022 781,072.00
Jun 30, 2022 488,782.00
Mar 31, 2022 834,647.00
Dec 31, 2021 500,921.00
Sep 30, 2021 594,632.00
API Access

Regenerative Medical Technology Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=RMTG&period=max&api_key=YOUR_API_KEY